Medical Research
(H01)
990 on File
COLORECTAL CANCER EQUITY FOUNDATION
Financial strength (30%)
35/100
Reliability (20%)
40/100
Effectiveness (25%)
31/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$21K
Total Revenue
$40K
Total Expenses
$-18,933
Net Assets
N/A
Employees
Revenue Sources
Program Expense Ratio
0.0%
Fundraising Efficiency
N/A
Operating Reserve
-5.64x
Liability-to-Asset
N/A
Revenue Diversification
100.0%
Compared with Peers
FY 2025
Compared with 378 similar organizations
(United States, Medical Research, under $100K in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
0.0% | 75.9% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
-5.6 mo | 44.2 mo |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
100.0% | 100.0% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
2483.1% | 2.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-52.1% | -2.5% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-88.6% | 20.0% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $21K | $40K | $-18,933 | 0.0% | — |
| 2024 | $827 | $84K | $0 | 0.0% | — |
| 2023 | $101K | $22K | $79K | 0.0% | — |
| 2022 | $712 | $1K | $-456 | 42.8% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.